Foresite Capital Management V, LLC
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), Foresite Capital Management V, LLC reported 9 stock positions worth $271.0 million. Its top holding was Alumis (ALMS) at 47.9% of the portfolio, followed by CG Oncology (CGON, 25.1%) and Disc Medicine (IRON, 8.8%). Compared with Q4 2025, it opened 3 new positions, sold out of 1, added to 3 and reduced 1. The biggest buy was Alumis (ALMS, shares +2%) and the biggest sale an exit from Natera (NTRA).
- Most Recent 13F
- Q2 2026
- Location
- WEST HOLLYWOOD, CA
- CIK
- 0001792206
- Portfolio Value
- $271.0M (Q1 2026)
- SEC Filing
- 0001104659-26-062464 ↗ filed May 15, 2026
Holdings Value
Holdings 9 stocks · $271.0M
| ALMS Alumis Inc. | 47.94% | 5,896,995 | $129.9M | Add +2.0% |
| CGON CG Oncology Inc. | 25.08% | 1,004,050 | $68.0M | No change |
| IRON Disc Medicine Inc. | 8.83% | 374,069 | $23.9M | Add +25.1% |
| HIMS Hims & Hers Health Inc. | 5.65% | 738,151 | $15.3M | Add +170.2% |
| EIKN Eikon Therapeutics Inc. | 5.15% | 1,318,983 | $14.0M | New |
| LYEL Lyell Immunopharma Inc. | 3.53% | 477,078 | $9.6M | No change |
| PHVS Pharvaris NV | 2.02% | 194,125 | $5.5M | New |
| NRIX Nurix Therapeutics Inc. | 1.52% | 265,000 | $4.1M | New |
| MAZE Maze Therapeutics Inc. | 0.29% | 25,905 | $773K | Reduce -70.0% |
Portfolio Sells Q4 2025 → Q1 2026
Portfolio Buys Q4 2025 → Q1 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $362.2M | ALMS, CGON, IRON, HIMS, PHVS |
| Q1 2026 | 9 | $271.0M | ALMS, CGON, IRON, HIMS, EIKN |
| Q4 2025 | 7 | $164.4M | ALMS, CGON, IRON, NTRA, LYEL |
| Q3 2025 | 6 | $108.7M | CGON, ALMS, IRON, HIMS, LYEL |
| Q2 2025 | 6 | $80.7M | CGON, ALMS, IRON, HIMS, MAZE |
| Q1 2025 | 6 | $87.6M | ALMS, CGON, IRON, HIMS, LYEL |
| Q4 2024 | 6 | $120.2M | ALMS, HIMS, CGON, IRON, CGEM |
| Q3 2024 | 5 | $143.9M | ALMS, HIMS, CGON, IRON, CGEM |
| Q2 2024 | 5 | $156.6M | ALMS, HIMS, CGON, IRON, CGEM |
| Q1 2024 | 5 | $106.5M | HIMS, CGON, IRON, KNTE, 23ANDME HOLDING CO |